Boston Scientific Corp. closed 12.60% below its 52-week high of $107.17, which the company achieved on February 5th.

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $118.54, a high ...

Shares of Boston Scientific Corp. BSX shed 4.27% to $92.64 Thursday, on what proved to be an all-around dismal trading ...

We came across a bullish thesis on Boston Scientific Corporation (BSX) on Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on BSX.

New US tariffs could disrupt the medtech industry, impacting major companies like Boston Scientific and Stryker. Read more ...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, ...

Truist lowered the firm’s price target on Boston Scientific (BSX) to $113 from $120 and keeps a Buy rating on the shares as part of a broad ...

We recently published a list of 10 Best Healthcare Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Boston Scientific Corporation (NYSE:BSX) stands ...

The intravascular lithotripsy market has undergone high growth trailblazed by J&J subsidiary Shockwave Medical.

We recently published a list of Jim Cramer Put These 16 Stocks Under a Microscope. In this article, we are going to take a look at where Edwards Lifesciences (NYSE:EW) stands against other stocks that ...

In a report released today, Travis Steed from Bank of America Securities maintained a Buy rating on Boston Scientific (BSX – Research Report).

The new tariffs announced by President Donald Trump Wednesday afternoon are weighing on some top names in the medtech industry, including Boston Scientific (NYSE:BSX), Stryker (NYSE:SYK), and ...